A4-02: Predictors of pathological early lung adenocarcinoma among clinical ia disease: possible indication for lesser surgical resection  by Suzuki, Kenji et al.
Copyright © 2007 by the International Association for the Study of Lung Cancer S319
Journal of Thoracic Oncology • Volume 2, Number 8, Supplement 4, August 2007  12th World Conference on Lung Cancer
with GP regimen was associated with a signiﬁcantly lower incidence 
of grade 3, 4 neutropenia than DP or TP (8.2% vs. 22.8% or 15.6 %, 
respectively: p=0.022), but the incidence of grade 3, 4 thromobocyto-
penia was higher (7.3% vs. 1.8% or 0%, respectively: p<0.0001). In pa-
tients older than 60 years, median time to progression was signiﬁcantly 
prolonged (171 days, 95% CI: 149~193) than the younger patients (97 
days, 95% CI: 70~24) (p<0.0003). However, overall survival was not 
different between the two age groups. Multivariate Cox regression 
analysis showed that the independent predictors of overall survival 
were stage and ECOG performance status.
Conclusions: There were no differences in survival advantages among 
the three regimens in the treatment of Korean patients with advanced 
non-small-cell lung cancer. 
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Objective: Non-small cell lung cancer (NSCLC) with pulmonary 
metastasis in the primary lobe (PM+) is classiﬁed as pathological stage 
IIIB. Although stage IIIB PM+ indicates a poor prognosis, this stage 
includes various subgroups with heterogeneous clinical outcome. Three 
possible mechanisms of intrapulmonary metastasis have been postulat-
ed: 1) via lymphatic vessel route, 2) blood vessel route, 3) airway route. 
Two of these metastatic mechanisms, the lymphatic and hematogenous 
spread by cancer cells, increase the chance of remote organ metastasis. 
Circulating tumor cells have a greater possibility of implanting distally 
and several investigators have actually described a positive correla-
tion between vessel invasion and distant metastasis or recurrence. On 
the other hand, a process in which tumor cells shed at the primary site 
implant and form a separate tumor via the airway route, namely aerog-
enous spread, is sometimes observed in primary lung cancer. Therefore, 
NSCLC with intrapulmonary metastasis via the aerogenous route might 
be regarded as local disease because of the absence of systemic dis-
semination via lymph vessels and blood vessels.
The objective of this study was to extract a subgroup of stage IIIB PM+ 
NSCLC patients with a better prognosis and assess their biological 
characteristics and metastatic mechanisms.
Methods: We reviewed 122 case of surgically resected stage IIIB PM+ 
NSCLC among the 1912 consecutive NSCLC patients who underwent 
complete surgical resection at our hospital between July 1992 and 
December 2004 and extracted a subgroup with a favorable outcome 
by univariate analysis of clinicopathological factors. The 15 cases 
without lymph-node metastasis and vessel invasion (PM+/N-/VI-) were 
extracted as the most favorable group. We assessed the clinicopatho-
logical features of the PM+/N-/VI- group in comparison with the other 
stage IIIB PM+ patients. 
Results: The survival rate of the PM+/N-/VI- group was signiﬁcantly 
better than in the other stage IIIB PM+ group (p=0.0042). Five-year 
disease-speciﬁc survival rates of the PM+/N-/VI- group and the other 
stage IIIB PM+ group were 91.7% and 39.5%, respectively. Microscop-
ic characteristics of the metastatic lesions suggesting that the cancer 
cells had implanted via the aerogenous route were seen in 86.7% of the 
PM+/N-/VI- group, as opposed to only 9.4% of the other PM+ cases 
(We considered that cancer cells with lepidic growth and no destruction 
of bronchovascular bundles and alveolar septa in the metastatic foci 
might have resulted from aerogenous spread whereas cancer cells that 
had formed solid nests and destroyed neighboring alveolar septa as they 
grew had not resulted from aerogenous metastasis). The histological 
type of primary tumors in the PM+/N-/VI- group was adenocarcinoma 
in every cases (p=0.021). Four were the mucinous BAC dominant sub-
type and 11 were the papillary dominant subtype. Furthermore, all 4 pa-
tients in the PM+/N-/VI- group who experienced a recurrence relapsed 
with intrapulmonary metastasis, not distant organ metastasis.
Conclusions: Stage IIIB PM+ cases via the airway route were enriched 
in the PM+/N-/VI- group and had extremely good survival rate. This 
group should be recognized as local disease and if relapse occurs in the 
remnant lobe, it may be possible of to achieve a cure by local therapy.
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Background: Early lung adenocarcinoma (ELA) can be frequently 
detected with thoracic computed tomography. The optimal management 
for those lesions still remains to be a matter of debate. Objectives: To 
clarify preoperative prognostic factors among clinical IA adenocarci-
noma of the lung. 
Patients and Methods: Between January of 2000 and December of 
2005, surgical resection was performed on 2175 lung cancer patients at 
National Cancer Center Hospital, Tokyo. A retrospective study was per-
formed on 444 lung cancers which met the following eligibility criteria: 
1) clinical IA disease, 2) histologically diagnosed adenocarcinoma, 
3) lobectomy or pneumonectomy performed, 4) thoracic thin-section 
CT available. We reviewed all of the above patients for preoperative 
clinico-radiological prognostic factors. Evaluated radiological factors 
were maximum tumor dimension, the presence of ground-glass opacity, 
the size of consolidation, the nature of consolidation (cloudy vs solid), 
pleural tail, and the presence of air bronchogram. Clinical factors were 
evaluated as to preoperative carcinoembryonic antigen (CEA) titer, 
gender and age. Uni- and multi-variate analyses were performed to 
detect predictors of pathological ELA, which was deﬁned as lung ad-
enocarcinoma without nodal disease, lymphatic invasion, nor vascular 
invasion.
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Results: Multivariate analysis revealed four signiﬁcant predictors of 
ELA: the presence of GGO, the size of consolidation, air-bronchogram, 
and CEA. The probability of ELA is evaluated based on the following 
equation. 
Conclusion: Pathological ELA can be predicted with four signiﬁcant 
preoperative factors. Based on these ﬁndings, candidate for limited 
surgical resection among clinical IA lung adenocarcinoma could be 
properly selected. Or other local therapy such as radiotherapy or radio-
frequency ablation, might be indicated for those tumors, though careful 
clinical trials are mandatory for evaluating the efﬁcacy of these new 
modalities. 
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Background: The aim of this study was twofold: to identify factors 
associated with in-hospital mortality among patients operated on for 
primary resectable lung cancer and to construct a risk model that could 
be used prospectively to inform decisions and retrospectively to enable 
comparisons and outcomes.
Methods: Data from a nationally representative thoracic surgery 
database were collected prospectively in 59 hospitals between June 1, 
2002 and February 1, 2006. Only adult patients with more than 95% of 
completed data were selected for the ﬁnal analysis (n=8,796 patients). 
Logistic regression analysis was used to predict the risk of in-hospital 
mortality. A risk model was developed with a training set of data (50% 
of patients) and validated on an independent test set (50% of patients). 
Its ﬁt was assessed by the Hosmer-Lemeshow test (larger p value signi-
ﬁes greater reliability), and predictive accuracy was indicated by the 
area under the receiver operating characteristic curve (c-index).
Results: Of the 10,205 original patients, 316 (3.1%) died during the 
same hospital admission. Within the data used to develop the model, 
the factors found to be signiﬁcantly associated with the occurrence of 
in-hospital mortality in a multivariate analysis were: age, gender, per-
formance status (World Health Organization) classiﬁcation, side, class 
of procedure (lobectomy or wedge resection versus pneumonectomy), 
tumor histology, TNM stages and presence of co-morbid disease. The 
model was reliable (Hosmer-Lemeshow test = 8.94; p=0.35) and accu-
rate: the c-index (95% conﬁdence interval) = 0.83 (0.81 to 0.85) for the 
training set and 0.82 (0.79 to 0.85) for the test set of data. The correla-
tion between the expected and observed number of deaths was 0.99.
Conclusions: The validated multivariate model for risk of in-hospital 
mortality among adult patients requiring surgery for primary resect-
able lung cancer described in this report was developed with national 
data, uses only 8 variables and has good performance characteristics. It 
would be useful both for calculating the mortality risk of an individual 
patient and contrasting expected and observed mortality rates for an 
institution or independent clinician.
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Background: Patients with mediastinal lymph node metastasis have 
a poor prognosis, and lung operation is not normally indicated. We 
have performed bilateral mediastinal lymph node dissection by median 
sternotomy to resect lung cancer and dissect the bilateral mediastinal 
lymph nodes. However, some studies have examined the communica-
tion between the left and right tracts in lung cancer cases, we anatomi-
cally analyzed this technique, and conﬁrmed its usefulness.
Methods: We have performed this operation in 266 patients with 
primary left lung cancer excluding small cell carcinoma and stageIV 
since 1987. Thirty out of 266 patients had p-N3 lymph node metasta-
ses. For anatomical study eighteen adult male cadavers were used to 
analyze the anatomical details. According to the macroscopic dissection 
procedure, dissection of the lymphatics from the lungs to the supra-
clavicular lymph nodes was performed by sequential removal of the 
related organs. We systematically compared and reviewed the route of 
lymphatic communications to the contralateral side with the anatomical 
signiﬁcance of left-to-right lymphatic communications in the bilateral 
mediastinal lymph nodes. 
Results: The overall 5-year survival rate (Kaplan-Meier method), 
including operative deaths and deaths due to unrelated diseases, was 
54.1% in the patients with left lung cancer. With respect to the p-N 
factor, the 5-year survival rate was 41.2% in p-N3 left lung cancer pa-
tients. Anatomical investigation showed left-to-right lymphatic commu-
nications in the following 4 regions: 1. regions around the brachioce-
phalic veins, 2. regions around the ascending aorta and the arch of the 
aorta, 3. regions around the trachea, 4. regions around the esophagus. 
Conclusions: We clariﬁed the route of lymphatic communications to 
the contralateral side, and systematically reviewed the anatomical sig-
niﬁcance of left-to-right lymphatic communications. We found various 
lymphatic communications such as between the left and right medi-
astinal lymph nodes and around the trachea in terms of clinical and 
anatomical status. Our results suggest the importance of the dissection 
of the bilateral mediastinal lymph nodes by median sternotomy.
